INT MEDICAL (01501) announced that, as of 28 February 2026, its H share capital remained at 139.41 million shares with a par value of RMB1 each, and its domestic share capital stood at 71.79 million shares at the same par value. The total issued share capital amounted to RMB211.20 million. The filing confirms no changes in the number of H shares and domestic shares during the reporting period, and no treasury shares were held. The company also stated that its public float remains in compliance with the 25.00% threshold requirement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments